Laboratory integration and utilization of tandem mass spectrometry in neonatal screening: a model for clinical mass spectrometry in the next millennium.
about
Screening newborns for metabolic disorders based on targeted metabolomics using tandem mass spectrometryRapid genotyping of single nucleotide polymorphisms influencing warfarin drug response by surface-enhanced laser desorption and ionization time-of-flight (SELDI-TOF) mass spectrometry.Neonatal screening for metabolic and endocrine disordersNewborn screening in Canada - Are we out of step?Metabolomics and its Application to the Development of Clinical Laboratory Tests for Prostate Cancer.Hypoglycemic Toxins and Enteroviruses as Causes of Outbreaks of Acute Encephalitis-Like Syndrome in Children, Bac Giang Province, Northern Vietnam
P2860
Laboratory integration and utilization of tandem mass spectrometry in neonatal screening: a model for clinical mass spectrometry in the next millennium.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Laboratory integration and uti ...... ometry in the next millennium.
@ast
Laboratory integration and uti ...... ometry in the next millennium.
@en
type
label
Laboratory integration and uti ...... ometry in the next millennium.
@ast
Laboratory integration and uti ...... ometry in the next millennium.
@en
prefLabel
Laboratory integration and uti ...... ometry in the next millennium.
@ast
Laboratory integration and uti ...... ometry in the next millennium.
@en
P2093
P1476
Laboratory integration and uti ...... ometry in the next millennium.
@en
P2093
P577
1999-12-01T00:00:00Z